Massachusetts General Hospital successfully performed its second pig-to-human kidney transplant using Eledon's tegoprubart as a key immunosuppressant, with the patient now off dialysis after two years.
A pooled analysis of Phase III clinical trials reveals that cognitive side effects following cranial radiation therapy for brain metastases may be fully reversible.